# Asthma-COPD Overlap

> Asthma-COPD overlap for NEET-PG Medicine: features that mark mixed disease in a smoker with variable airflow limitation, and the inhaler strategy.

- Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/asthma-copd-overlap
- Exam / course: NEET-PG · Subject: Medicine
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Harrison's Principles of Internal Medicine; GOLD Report on COPD; Global Initiative for Asthma (GINA) report
- How to cite: "Asthma-COPD Overlap", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/asthma-copd-overlap

## Direct answer

Asthma-COPD overlap describes persistent airflow limitation in a patient with features of both asthma and COPD, most often a smoker with early-onset atopy or raised eosinophils. It is suspected when the post-bronchodilator FEV1 to FVC ratio stays below 0.7 alongside several asthma-type features. Treatment usually starts with an inhaled corticosteroid combined with a long-acting bronchodilator, rather than a COPD-only regimen.

## What you must remember

- **Persistent airflow limitation:** a post-bronchodilator FEV1/FVC below 0.7 is the spirometric anchor for the overlap.
- **Asthma features:** onset before age 40, atopy, a family history of asthma, and variable symptoms including night waking.
- **COPD features:** smoking exposure above about 10 pack-years, age over 40, and chronic cough or sputum production.
- **Eosinophils:** raised blood eosinophils, around 300 cells per microlitre or more, predict a response to inhaled corticosteroids.
- **Reversibility:** a significant bronchodilator response supports an asthma component, although it can be modest in COPD and in overlap.
- **Treatment:** an inhaled corticosteroid with a long-acting beta agonist is the usual start, with a long-acting muscarinic antagonist added if symptoms persist.
- **Indian mimics:** biomass smoke exposure, bronchiectasis and tuberculosis must be excluded when the picture is atypical or sputum persists.

## Building the overlap diagnosis

Overlap is a label that needs spirometry and a feature count, not a guess from age alone. The steps separate true overlap from simple asthma or simple COPD.

1. **Confirm airflow limitation:** A post-bronchodilator FEV1/FVC below 0.7 establishes persistent airflow limitation, which is needed before the overlap label is applied.
2. **Score the asthma features:** Record early onset, atopy, variable symptoms, bronchodilator response and blood eosinophil count, since several features are needed.
3. **Score the COPD features:** Record smoking history above about 10 pack-years, age over 40, chronic cough or sputum, and any biomass smoke exposure.
4. **Match the pattern:** Overlap is assigned when features of both diseases are present, with the stronger pattern guiding the working label.
5. **Choose inhaler therapy:** An inhaled corticosteroid with a long-acting beta agonist is started, and a long-acting muscarinic antagonist is added if symptoms or exacerbations persist.
6. **Review and exclude mimics:** Repeat spirometry and eosinophil counts, and consider tuberculosis or bronchiectasis when sputum persists or the picture is atypical.

## Where the overlap gets missed

Overlap questions often hinge on one feature that the student overlooks, usually the atopy history or the spirometry ratio.

- **Trap:** labelling every smoker with airflow limitation as pure COPD — **Correct:** early-onset atopy or raised eosinophils are overlap features, and steroid-containing therapy can then help.
- **Trap:** using FEV1 alone to define airflow limitation — **Correct:** the post-bronchodilator FEV1/FVC ratio below 0.7 is the criterion, because FEV1 alone does not separate obstruction from restriction.
- **Trap:** assuming persistent sputum in a biomass-exposed woman is simply COPD — **Correct:** tuberculosis and bronchiectasis are common mimics, so investigation should be considered before settling on the diagnosis.

## Frequently asked questions

### What defines asthma-COPD overlap?
Asthma-COPD overlap is defined by persistent airflow limitation with several features of both asthma and COPD. It is a descriptive label rather than a single disease (current GINA and GOLD reports no longer treat it as a distinct entity), and it guides the choice of inhaler therapy.

### Which spirometry result confirms persistent airflow limitation?
A post-bronchodilator FEV1 to FVC ratio below 0.7 confirms persistent airflow limitation, which is needed before asthma-COPD overlap is diagnosed. Without this result, a patient with variable asthma symptoms cannot be placed in the overlap group.

### Which features point to an asthma component in a long-term smoker?
Early onset before age 40, atopy, a family history of asthma and a significant bronchodilator response point to an asthma component in a smoker. Raised blood eosinophils also suggest that inhaled corticosteroids will help in asthma-COPD overlap.

### Which inhaler is usually started in asthma-COPD overlap?
An inhaled corticosteroid with a long-acting beta agonist is usually started in asthma-COPD overlap, with a long-acting muscarinic antagonist added if symptoms persist. The steroid component addresses the asthma features, while the bronchodilators treat the airflow limitation.